Caricamento...
Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology
Induced pluripotent stem cell (iPSC) technology is increasingly being used to create in vitro models of monogenic human disorders. This is possible because, by and large, the phenotypic consequences of such genetic variants are often confined to a specific and known cell type, and the genetic varian...
Salvato in:
| Pubblicato in: | Front Endocrinol (Lausanne) |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047192/ https://ncbi.nlm.nih.gov/pubmed/33868170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.635662 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|